P-617 Gefitinib (ZD 1839, Iressa) as a last option for...

Lung Cancer 2003 / 8 Vol. 41

P-617 Gefitinib (ZD 1839, Iressa) as a last option for patients with recurrent non-small cell lung cancer (NSCLC)

Haringhuizen, Annebeth, Vaessen, Heleen F.R., Baas, Paul, van Zandwijk, Nico
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
41
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)92584-0
Date:
August, 2003
File:
PDF, 189 KB
english, 2003
Conversion to is in progress
Conversion to is failed